Fedratinib FDR Impuity 2

Fedratinib FDR Impuity 2 Or ( N-(tert-butyl)-3-((2-chloro-5-methylpyrimidin-4-yl)amino)benzenesulfonamide hydrochloride is an associate impurity of Fedratinib. Fedratinib is employed to treat adults with certain types of myelofibrosis. Fedratinib is during a category of medicines known as kinase inhibitors.

Additional information

Catalogue No.

VE007860

CAS No.

N/A

Molecular Formula

C15H20Cl2N4O2S

Molecular Weight

391.32 g/mol

IUPAC Name

N-(tert-butyl)-3-((2-chloro-5-methylpyrimidin-4-yl)amino)benzenesulfonamide hydrochloride

References

“Sci-Hub, Safety and Efficacy of Fedratinib in Patients with Primary or Secondary Myelofibrosis. JAMA Oncology, 1(5), 643, 10.1001/Jamaoncol.2015.1590.” Sci-Hub.se, 2015, sci-hub.se/jamanetwork.com/journals/jamaoncology/article-abstract/2330618.

Status

In-stock